Benralizumab in severe eosinophilic asthma by previous biologic use and key clinical subgroups: real-world XALOC-1 programme
贝那利珠单抗治疗重度嗜酸性粒细胞性哮喘,按既往生物制剂使用情况和关键临床亚组进行分组:真实世界 XALOC-1 项目
期刊:European Respiratory Journal
影响因子:21
doi:10.1183/13993003.01521-2023
Jackson, David J; Pelaia, Girolamo; Emmanuel, Benjamin; Tran, Trung N; Cohen, David; Shih, Vivian H; Shavit, Anat; Arbetter, Douglas; Katial, Rohit; Rabe, Adrian Paul J; Garcia Gil, Esther; Pardal, Marisa; Nuevo, Javier; Watt, Michael; Boarino, Silvia; Kayaniyil, Sheena; Chaves Loureiro, Cláudia; Padilla-Galo, Alicia; Nair, Parameswaran